SCHEMBL3895041

SCHEMBL3895041

NNC[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2428440 0.67
SCHEMBL44518 0.65
SCHEMBL208575 0.64
SCHEMBL11213851 0.62
SCHEMBL1051910 0.61
SCHEMBL10840976 0.61
SCHEMBL9407380 0.61
SCHEMBL2698920 0.61
SCHEMBL2638354 0.61
SCHEMBL28112235 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4323517-A2 COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES AND PROCESSES RELATED TO ALTERATION OF THEIR PHYSICOCHEMICAL CHARACTERISTICS Sixfold Bioscience Ltd. (GB) 2024-02-21 EP claimed
JP-3545399-B2 2004-07-21 JP claimed
EP-0646180-B1 METHODS FOR INACTIVATING NUCLEOTIDE SEQUENCES AND METAL CHELATES FOR USE THEREIN ABBOTT LAB (US) 2002-02-27 EP claimed
US-5929103-A ANTICARCINOGENIC AGENTS DONG WHA PHARM. IND. CO., LTD. (KR) 1999-07-27 US claimed
EP-0646180-A4 METHODS FOR INACTIVATING NUCLEOTIDE SEQUENCES AND METAL CHELATES FOR USE THEREIN. ABBOTT LAB (US) 1998-03-11 EP claimed
EP-0646180-A1 METHODS FOR INACTIVATING NUCLEOTIDE SEQUENCES AND METAL CHELATES FOR USE THEREIN ABBOTT LABORATORIES (US) 1995-04-05 EP claimed
WO-1993020241-A1 METHODS FOR INACTIVATING NUCLEOTIDE SEQUENCES AND METAL CHELATES FOR USE THEREIN ABBOTT LABORATORIES (US) 1993-10-14 WO claimed
WO-2022264114-A2 ROS SENSITIVE DIAZABORINES FOR THE CONSTRUCTION OF STIMULI-RESPONSIVE BIOCONJUGATES TECHNOPHAGE, INVESTIGAÇÃO E DESENVOLVIMENTO EM BIOTECHNOLOGIA, S.A. (PT) 2022-12-22 WO disclosed
EP-2807162-B1 SUBSTITUTED PHENYLIMIDAZOPYRAZOLES AND USE THEREOF Bayer Pharma AG (DE) 2017-06-07 EP disclosed
CN-103961901-B Method for removing long-chain carboxylate and hydrocarbon in alcohol amine solution PETROCHINA COMPANY LIMITED (CN) 2016-04-06 CN disclosed
EP-2807162-A1 SUBSTITUTED PHENYLIMIDAZOPYRAZOLES AND USE THEREOF Bayer Pharma Aktiengesellschaft (DE) 2014-12-03 EP disclosed
CN-103961901-A Method for removing long-chain carboxylate and hydrocarbon in alcohol amine solution PETROCHINA CO LTD 2014-08-06 CN disclosed
WO-2013110590-A1 SUBSTITUTED PHENYLIMIDAZOPYRAZOLES AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2013-08-01 WO disclosed
WO-1993020241-A1 METHODS FOR INACTIVATING NUCLEOTIDE SEQUENCES AND METAL CHELATES FOR USE THEREIN ABBOTT LABORATORIES (US) 1993-10-14 WO disclosed
WO-1993005162-A1 METHOD FOR DELIVERING NUCLEIC ACIDS INTO CELLS THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) 1993-03-18 WO disclosed
US-5128371-A Acylated naphthlamines as plant fungicides CIBA-GEIGY CORPORATION (US) 1992-07-07 US disclosed
US-4916157-A Acylated naphthylamines as plant fungicides CIBA-GEIGY CORPORATION (US) 1990-04-10 US disclosed
EP-0252482-A2 7-Acyloxy-6-aminoacyloxypolyoxylabdanes, process for their preparation and their use as medicine HOECHST AKTIENGESELLSCHAFT (DE) 1988-01-13 EP disclosed
EP-0217372-A2 Polyoxygenated labdane derivatives, process for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1987-04-08 EP disclosed
EP-0150036-A1 Azolyl-aryl-alkanole-derivatives, processes for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1985-07-31 EP disclosed